WednesdayJul 13, 2022 9:00 am

Homing Peptides: Silo Pharma Inc. (SILO) Targets ADRs

Silo’s partnership with UMB could yield therapeutics that limit side effects through precisely targeted delivery On February 3, 2022, Silo Pharma (OTCQB: SILO) extended its research partnership with the University of Maryland, Baltimore (“UMB”) to explore potentially lifesaving joint-homing peptides that target inflamed endothelium (a thin membrane that lines the inside of the heart and blood vessels). The ability to target inflamed tissue (while bypassing healthy organs) suggests joint-homing peptides could deliver therapeutics or fusion imaging nanoparticles to specific diseased tissues. Better imaging, lower radiation and precision, targeted dosing could enhance the therapeutic effect of current and future therapeutics and…

Continue Reading

TuesdayJul 12, 2022 4:43 pm

QualityStocksNewsBreaks – Silo Pharma Inc. (SILO) Announces Positive Results of New Study

Silo Pharma (OTCQB: SILO), a development-stage biopharmaceutical company, today announced that its novel liposomes reached a positive endpoint in animal studies showing effectiveness and reduced toxicity using a subcutaneous delivery method. “The successful results of our study show that the subcutaneous route of liposomal administration is well-suited for use in targeted drug delivery of anti-arthritic agents. We suggest that this drug delivery approach would not only enhance efficacy but also reduce systemic toxicity,” said Eric Weisblum, CEO of Silo Pharma. “In our previous work, ART-1-Cy7-liposomes injected i.v. demonstrated homing to arthritic joints and four hours was an optimal time point…

Continue Reading

TuesdayJul 12, 2022 3:21 pm

QualityStocksNewsBreaks – Cybin Inc.’s (NYSE American: CYBN) (NEO: CYBN) CYB003 Phase 1/2a Clinical Trial Through Clinilabs Begins Enrollment

Clinilabs Drug Development Corporation, a global, full-service contract research organization with deep expertise in central nervous system drug development, today announced commencement of enrollment in a phase 1/2a clinical trial of CYB003. Being developed by Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” CYB003 is the first novel psilocybin analog to be evaluated in phase 1/2a development for the treatment of major depressive disorder (“MDD”). “Clinilabs is honored to be working with Cybin, an innovator in the development of novel psychedelic therapeutics, to conduct its first-in-human clinical trial of CYB003,” said…

Continue Reading

TuesdayJul 12, 2022 2:52 pm

QualityStocksNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0) Announces Promotion of Patrick Dunn to CFO, Director

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0), a publicly-traded investment company, today announced it has promoted its Vice President, Finance Patrick Dunn to CFO and has appointed him as a member of the company’s board of directors. Dunn, CPA, a founding partner of Dunn, Pariser & Peyrot, is an experienced senior executive with a proven track record of investing in and building highly successful agribusinesses throughout North America. “We are proud to promote Patrick Dunn to CFO of Eat Well Group and to have him join the board of directors of the company. His first-hand experience in…

Continue Reading

TuesdayJul 12, 2022 2:45 pm

QualityStocksNewsBreaks – Home Bistro Inc. (HBIS) Announces New Pricing Plan Following Successful Beta Test

Home Bistro (OTC: HBIS), a leading online meal-delivery platform that offers celebrity chef-inspired, gourmet and lifestyle ready-made meals, is planning on rolling out a new three-tiered pricing plan, effective Aug. 1, 2022. The announcement comes after the company saw positive results from beta testing of the enhanced meal-pricing structure. “Over the past six months, we have spent considerable time studying ways to reduce our product costs while expanding our top line revenue and increasing gross profit margin,” said Home Bistro CEO Zalmi Duchman in the press release. “By analyzing the current market and closely studying the value proposition of alternative…

Continue Reading

TuesdayJul 12, 2022 2:20 pm

QualityStocksNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Upgrades EDI to Include Location Sharing, Shipment Status Improvements

Freight Technologies (NASDAQ: FRGT), a technology company developing solutions to optimize and automate the supply chain process and providing a platform for B2B cross-border shipping in the NAFTA region, announced that it has upgraded its electronic data interchange (“EDI”). The upgraded EDI now features the ability to enable location sharing and shipment status changes. “To help increase Fr8App large shippers’ efficiency and the stickiness of our application, we continue to improve our EDI, which increases notification speed and reduces costs with our agile, paperless electronic exchange of data,” said Fr8Tech and Fr8App CEO Javier Selgas in the press release. “Recently,…

Continue Reading

TuesdayJul 12, 2022 12:00 pm

Emerging iGaming Technology Trends Fuel Golden Matrix Group Inc.’s (NASDAQ: GMGI) B2B Growth Strategy

Enhanced graphics, Gamification, AI-powered loyalty systems and data analytics redefining iGaming experience and generating higher player yields for online operators. GMGI sets industry standard, offers 10,000+ games across 25+ providers Company provides highly configurable, modular, white-label, turnkey gaming platforms compatible with all major operating systems, browsers, devices Company recently reported 221% Q2-2022 growth, 15 consecutive profitable quarters  Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems, and gaming content, continues its steady growth trajectory by leveraging several emerging technology trends. In particular, the company is leveraging its go-to Loyalty platform that incorporates a Gamification component.…

Continue Reading

TuesdayJul 12, 2022 11:15 am

Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Reports Growth, Ongoing Optimism for Natural Food Brands Amid Market Pressures

Plant-based foods investment company Eat Well Investment Group Inc. has positioned itself to respond to global food needs exacerbated by the COVID pandemic and the war in Ukraine, and it reports its subsidiaries are in the right place to help deal with food sector concerns Eat Well recently announced its annual financial data and Q1 2022 data, showing its Amara baby food subsidiary achieved revenue gains of 320 percent this year over the previous year The company also reported it is on target to achieve this year’s revenue goals of $90 million to $110 million Fears that a recession will…

Continue Reading

TuesdayJul 12, 2022 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Technology Enhances Bioavailability of Orally Administered APIs

Lexaria is a global innovator in drug delivery platforms The company has developed the patented DehydraTECH(TM) technology that significantly improves the bioavailability of orally administered pharmaceuticals and therapeutics Bioavailability is the fraction of a drug that reaches the site of action or systemic circulation While drugs delivered intravenously are 100% bioavailable, drugs that have any other route of administration, such as oral, have reduced bioavailability DehydraTECH enhances the bioavailability of APIs, in part, by bypassing first-pass liver processing Global innovator Lexaria Bioscience (NASDAQ: LEXX) has built a reputation as a developer of drug delivery platforms, the most notable of which…

Continue Reading

TuesdayJul 12, 2022 10:00 am

QualityStocksNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Milestone Agreement with DPL Featured in NGT News Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, recently signed a binding agreement with DelPack Logistics LLC (“DPL”), an Amazon delivery service partner, for DPL to purchase up to 600 Mullen Class 2 EV cargo vans over a period of 18 months. The vans will be fully homologated for the United States, of which the first 300 can be delivered by Nov. 30, 2022, at the request of DPL. “This agreement is a milestone for Mullen Automotive,” David Michery, CEO and chairman of MULN was quoted as saying in an article published by NGT News. “DelPack is a…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered